Clinical Trial

Prucaloprida vs Bisacodyl as a Stimulant in Bowel Preparation for Video Colonoscopy in Adults

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 17, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this randomized clinical trial is to compare prucalopride versus bisacodyl as a stimulant agent for bowel cleansing preparation prior to colonoscopy in patients undergoing the procedure at the Endoscopy Unit of the Hospital de Clínicas. The main research questions this study aims to answer are: Is prucalopride superior or equivalent to bisacodyl as a stimulant agent for bowel cleansing preparation before colonoscopy? Is the tolerability of prucalopride better, equivalent, or worse compared to bisacodyl? The investigators will compare the standard bowel cleansing preparation using polyethylene glycol (PEG) in combination with either bisacodyl or prucalopride as the stimulant agent. Participants will be randomized into two groups, both receiving the same base preparation with different stimulant agents.
Trial Details
NCT Number NCT07127237
Lead Sponsor Hospital de Clínicas Dr. Manuel Quintela
Conditions Bowel Preparation
Enrollment 124 participants
Start Date 2025-09
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-08-17